NCT04640285View on ClinicalTrials.gov

Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by Smokers

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

March 12, 2021

Study Completion Date

March 19, 2021

Conditions
Electronic Cigarette Use
Interventions
OTHER

RELX ENDS Tobacco Flavor

Ad libitum use of RELX ENDS tobacco flavor product during 8-hour and 5-minute use sessions

OTHER

RELX ENDS Menthol Flavor

Ad libitum use of RELX ENDS Menthol flavor product during 8-hour and 5-minute use sessions

OTHER

Usual Brand Cigarette

Ad libitum use of subjects usual brand product during 8-hour and single cigarette use sessions

OTHER

Nicorette White Ice Mint nicotine polacrilex gum

Ad libitum use of Nicorette White Ice Mint nicotine polacrilex gum product during 8-hour and 30-minute use sessions

Trial Locations (1)

66212

Altasciences Clinical Kansas, Inc, Overland Park

All Listed Sponsors
lead

Cheerain HK Limited

INDUSTRY

NCT04640285 - Nicotine Uptake, Measures of Abuse Liability, and Puffing Topography With Use of RELX ENDS Products by Smokers | Biotech Hunter | Biotech Hunter